Diagnosis of cryptococcosis and prevention of cryptococcal meningitis using a novel point-of-care lateral flow assay

Case Reports in Medicine

Volumn 2013, Issue , 2013, Pages

  Dhana, Ashar ^a  

^a HELEN JOSEPH HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTRIAXONE; CORTICOSTEROID; COTRIMOXAZOLE; EFAVIRENZ; EMTRICITABINE; FLUCONAZOLE; GLUCOSE; HEMOGLOBIN; MAGNESIUM; PARACETAMOL; POTASSIUM; TENOFOVIR;

ABNORMAL LABORATORY RESULT; ADULT; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; DAY HOSPITAL; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FEVER; FOLLOW UP; GENERALIZED LYMPHADENOPATHY; GLUCOSE BLOOD LEVEL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HIV TEST; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTRACRANIAL PRESSURE; LATERAL FLOW ASSAY; LOSS OF APPETITE; LUMBAR PUNCTURE; LYMPHOCYTE COUNT; MALE; NEUROLOGIC EXAMINATION; NEUTROPHIL COUNT; PALLOR; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; TACHYCARDIA; WEIGHT REDUCTION;

EID: 85029295580     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2013/640216     Document Type: Article

References (17)

1. Antinori S., New insights into HIV/AIDS-associated cryptococcosis. ISRN AIDS 2013 2013 22 471363 10.1155/2013/471363
2. Datta K., Bartlett K. H., Baer R., Byrnes E., Galanis E., Heitman J., Hoang L., Leslie M. J., MacDougall L., Magill S. S., Morshed M. G., Marr K. A., Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. Emerging Infectious Diseases 2009 15 8 1185 1191 2-s2.0-68049107386 10.3201/eid1508.081384
3. Khan Z. U., Randhawa H. S., Kowshik T., Chowdhary A., Chandy R., Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in North-Western India. Journal of Antimicrobial Chemotherapy 2007 60 2 312 316 2-s2.0-34547841547 10.1093/jac/dkm192 (Pubitemid 47243879)
4. Park B. J., Wannemuehler K. A., Marston B. J., Govender N., Pappas P. G., Chiller T. M., Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009 23 4 525 530 2-s2.0-62349130224 10.1097/QAD.0b013e328322ffac
5. Jarvis J. N., Meintjes G., Williams A., Brown Y., Crede T., Harrison T. S., Adult meningitis in a setting of high HIV and TB prevalence: Findings from 4961 suspected cases. BMC Infectious Diseases 2010 10, article 67 2-s2.0-77949448641 10.1186/1471-2334-10-67
6. Boulware D. R., Meya D. B., Bergemann T. L., Wiesner D. L., Rhein J., Musubire A., Lee S. J., Kambugu A., Janoff E. N., Bohjanen P. R., Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Medicine 2010 7 12 2-s2.0-78650498612 10.1371/journal.pmed.1000384 e1000384
7. Tanner D. C., Weinstein M. P., Fedorciw B., Joho K. L., Thorpe J. J., Reller L. B., Comparison of commercial kits for detection of cryptococcal antigen. Journal of Clinical Microbiology 1994 32 7 1680 1684 2-s2.0-0028365806 (Pubitemid 24189556)
8. Rajasingham R., Meya D. B., Boulware D. R., Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care. Journal of Acquired Immune Deficiency Syndromes 2012 59 5 e85 e91 2-s2.0-84859773709 10.1097/QAI.0b013e31824c837e
9. Jarvis J. N., Percival A., Bauman S., Pelfrey J., Meintjes G., Williams G. N., Longley N., Harrison T. S., Kozel T. R., Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clinical Infectious Diseases 2011 53 10 1019 1023 2-s2.0-80054757511 10.1093/cid/cir613
10. French N., Gray K., Watera C., Nakiyingi J., Lugada E., Moore M., Lalloo D., Whitworth J. A. G., Gilks C. F., Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002 16 7 1031 1038 2-s2.0-0037013093 10.1097/00002030-200205030-00009 (Pubitemid 34499426)
11. Jarvis J. N., Lawn S. D., Vogt M., Bangani N., Wood R., Harrison T. S., Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clinical Infectious Diseases 2009 48 7 856 862 2-s2.0-63649125348 10.1086/597262
12. Jarvis J. N., Meintjes G., Wood R., Harrison T. S., Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme. AIDS 2010 24 8 1233 1235 2-s2.0-77951832171 10.1097/QAD.0b013e3283383aeb
13. Peeling R. W., Mabey D., Point-of-care tests for diagnosing infections in the developing world. Clinical Microbiology and Infection 2010 16 8 1062 1069 2-s2.0-77955162595 10.1111/j.1469-0691.2010.03279.x
14. McMullan B. J., Halliday C., Sorrell T. C., Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS ONE 2012 7 11 e49541 10.1371/journal.pone.0049541
15. Lindsley M. D., Mekha N., Baggett H. C., Surinthong Y., Autthateinchai R., Sawatwong P., Harris J. R., Park B. J., Chiller T., Arunmozhi Balajee S., Poonwan N., Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clinical Infectious Diseases 2011 53 4 321 325 2-s2.0-79961218158 10.1093/cid/cir379
16. Hansen J., Slechta E. S., Gates-Hollingsworth M. A., Neary B., Barker A. P., Bauman S., Kozel T. R., Hanson K. E., Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clinical and Vaccine Immunology 2013 20 1 52 55 10.1128/CVI.00536-12
17. Meya D. B., Manabe Y. C., Castelnuovo B., Cook B. A., Elbireer A. M., Kambugu A., Kamya M. R., Bohjanen P. R., Boulware D. R., Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count ≤100 cells/ L who start HIV therapy in resource-limited settings. Clinical Infectious Diseases 2010 51 4 448 455 2-s2.0-77955743248 10.1086/655143